Zymeworks, Inc. (ZYME)
23.32
-0.58
(-2.41%)
USD |
NASDAQ |
Mar 20, 16:00
23.50
+0.18
(+0.77%)
After-Hours: 20:00
Zymeworks Research and Development Expense (Quarterly) : 31.24M for Dec. 31, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Royalty Pharma Plc | 51.00M |
| Krystal Biotech, Inc. | 13.23M |
| Scholar Rock Holding Corp. | 46.45M |
| Xeris Biopharma Holdings, Inc. | 7.874M |
| Stoke Therapeutics, Inc. | 41.29M |